AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18840257
Drug: Baclofen in
RxNorm normalized name: baclofen Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen in combination with alcohol
Trial: 16720445
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS) 200 microg once daily (QD)
Trial: 15176158
Drug: Low-dose doxycycline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose doxycycline hyclate
Trial: 1706531
Drug: Lactated Ringer
RxNorm normalized name: lactated ringers
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer solution (LRS)
Trial: 10502592
Drug: Transmyocardial revascularization
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TRANSENDOCARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmyocardial revascularization followed by continued medical therapy
Trial: 10211032
Drug: Bupivacaine 75
RxNorm normalized name: bupivacaine hydrochloride 3.75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 75 mg in 0.9% saline 60 ml and epinephrine 5 micrograms/ml
Trial: 30792988
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg efavirenz
Trial: 30792988
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg efavirenz
Trial: 22508376
Drug: Carbidopa 450
RxNorm normalized name: Carbidopa
DrugBank: Carbidopa (DB00190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbidopa 450 mg/day
Trial: 19879596
Drug: Colesevelam 3.75
RxNorm normalized name: colesevelam 3.75 g oral powder for reconstitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colesevelam 3.75 g/d
Trial: 7770708
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole
Trial: 326384
Drug: CMF chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF chemotherapy
Trial: 9613540
Drug: Interpleural injections
RxNorm normalized name: bleomycin
DrugBank: Bleomycin (DB00290)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interpleural injections via a catheter (20 mL 0.25%, 4-6 times per day for 3-6 days; n = 25 for right, n = 12 for left)
Trial: 6111295
Drug: Clemastine fumarate
RxNorm normalized name: Clemastine Fumarate
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine fumarate (antihistamine H1-antagonist)
Trial: 23573238
Drug: Hydroxyethyl cellulose
RxNorm normalized name: Hydroxyethyl Cellulose
DrugBank: Hydroxyethyl cellulose (DB11602)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl cellulose placebo gel
Trial: 2299491
Drug: Biofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback treatment
Trial: 22429760
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg as needed (PRN)
Trial: 28324627
Drug: Buprenorphine induction
RxNorm normalized name: buprenorphine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine induction and dose stabilization during hospitalization followed by post-discharge transition to office-based buprenorphine treatment (OBOT)
Trial: 1587064
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg proguanil alone
Trial: 1587064
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg proguanil with 100 mg racemic mephenytoin
Trial: 12511310
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (0.6 mg/kg)
Trial: 19525739
Drug: Monotherapy (MT)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (MT)
Trial: 19129751
Drug: EVT 301
RxNorm normalized name: EVT 201
DrugBank: EVT 201 (DB05721)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EVT 301 (25 mg)
Trial: 9113121
Drug: Tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5 mg
Trial: 12008682
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (once or twice daily)
Trial: 23432755
Drug: low-level TAC
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low-level TAC (3-7 μg/L) and high-level SIR (8-12 μg/L) (TACL/SIR(H), n=140)
Trial: 9677830
Drug: Anticardiolipin antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticardiolipin antibodies (IgM)
Trial: 23687231
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (group P; n = 75)
Trial: 23687231
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (group P)
Trial: 20139427
Drug: Vaginal levonorgestrel
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Vaginal levonorgestrel (1.5 mg single dose on LH + 2; n = 7)
Trial: 19676125
Drug: 360 microg
RxNorm normalized name: Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 microg PEG‐IFNalpha‐2a weekly plus ribavirin at 1000‐1200 mg/day for 12 weeks
Trial: 19676125
Drug: 180 microg
RxNorm normalized name: Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 microg PEG‐IFNalpha‐2a weekly plus ribavirin at 1000‐1200 mg/day for 12 weeks
Trial: 8934728
Drug: FEC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEC with high-dose infusional 5-fluorouracil
Trial: 2391398
Drug: flurbiprofen 200
RxNorm normalized name: flurbiprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: flurbiprofen 200 mg plus cimetidine 300 mg qid for 7 days before and for 2 days after receiving flurbiprofen
Trial: 19505968
Drug: 0.7 ml
RxNorm normalized name: ethanol 0.7 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 ml kg(‐1) of contrast material injected with a fixed duration of 10 s (Group C)
Trial: 22175055
Drug: 90 mL
RxNorm normalized name: 190 ML Infugem 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mL of sodium phosphate (NaP)
Trial: 3010626
Drug: Diazepam at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam at 0.3 mg . kg‐1
Trial: 7706572
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide inhaled at 64 vpm
Trial: 7706572
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide inhaled at 512 vpm
Trial: 29580238
Drug: Community Health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community Health Workers (CHWs) treatment for SAM
Trial: 21029339
Drug: Aliskiren 300
RxNorm normalized name: aliskiren 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 300 mg
Trial: 8184997
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (cognitive behavioral treatment + supportive drug maintenance)
Trial: 23187888
Drug: Microdose of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microdose of zidovudine (100 μg)
Trial: 22664978
Drug: Ropivacaine 0.75%
RxNorm normalized name: ROPivacaine 0.75% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.75% 20 mL
Trial: 23094720
Drug: Class IC
RxNorm normalized name: Antiarrhythmics, class Ic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class IC or class III antiarrhythmic agents
Trial: 6619270
Drug: Carbamazepine treatment
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine treatment (3-5 weeks)
Trial: 9535315
Drug: Carbamazepine treatment
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine treatment
Trial: 26986171
Drug: Radioiodine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine therapy (3.7 and 4.62 GBq)
Trial: 1346337
Drug: Late therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late therapy
Trial: 30243957
Drug: Low-dose lipopolysaccharide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose lipopolysaccharide (LPS, 0.4 ng/kg body weight)
Trial: 28393342
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care program (12 weeks)
Trial: 3538995
Drug: Theophylline monohydrate
RxNorm normalized name: Theophylline monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline monohydrate (281.7 mg)
Trial: 3928264
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoprofen
Trial: 20500134
Drug: Antibiotics (amoxicillin)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotics (amoxicillin)
Trial: 7133974
Drug: Pentazocin 100
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentazocin 100 mg
Trial: 10658936
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A (8 mg/kg) followed by L-NMMA
Trial: 2894357
Drug: Nitrendipine alone
RxNorm normalized name: nitrendipine
DrugBank: Nitrendipine (DB01054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine alone or in combination with hydrochlorothiazide or propranolol or both
Trial: 20940567
Drug: PSP clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSP clinical pathway applied to treatment group (n = 30)
Trial: 10587552
Drug: Hormonal Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal Replacement Therapy (HRT) - conjugated oestrogen 0.625 mg daily from day 1 to day 21 plus medroxyprogesterone acetate 5 mg daily days 10-21
Trial: 25725179
Drug: Continuous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuous low-dose methylprednisolone infusion
Trial: 12490789
Drug: Reduced-dose CsA
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced-dose CsA plus concentration-controlled SRL (troughs 10-20 ng/mL; group B, n=100)
Trial: 18324951
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg once weekly (OW)
Trial: 27306581
Drug: Flunarizine 10
RxNorm normalized name: flunarizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine 10 mg/d
Trial: 24948345
Drug: PTH 1-34
RxNorm normalized name: PTH 1-34
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: PTH 1-34 delivered via twice-daily injection
Trial: 1582305
Drug: Early adjunctive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early adjunctive corticosteroids for Pneumocystis pneumonia
Trial: 4076329
Drug: Indocyanine green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indocyanine green 0.15 mg/kg intravenously
Trial: 27007392
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (4 g)
Trial: 26745694
Drug: Iniparib 8
RxNorm normalized name: Iniparib
DrugBank: Iniparib (DB13877)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iniparib 8 mg/kg intravenously on days 1 and 4 weekly
Trial: 25065093
Drug: 400 ml
RxNorm normalized name: Lantidra 400 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 ml 10% CHO drink preoperative night and 2 hours before anesthesia
Trial: 20463641
Drug: Calcineurin inhibitor
RxNorm normalized name: Calcineurin inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcineurin inhibitor (CsA)
Trial: 15459842
Drug: Carbonic anhydrase
RxNorm normalized name: Carbonic anhydrase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbonic anhydrase inhibitors (n = 26)
Trial: 15459842
Drug: None of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: None of these drugs (n = 258)
Trial: 21769873
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (0 mg kg(‐1))
Trial: 1398851
Drug: Chloramphenicol succinate
RxNorm normalized name: Chloramphenicol succinate
DrugBank: Chloramphenicol succinate (DB07565)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloramphenicol succinate (CS) 50 mg/kg/day
Trial: 9081358
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 2.4 mg/kg
Trial: 11382722
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with abciximab
Trial: 8023659
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural administration of 50 micrograms sufentanil
Trial: 31804890
Drug: Acetazolamide (AZ)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (AZ) 500 mg/day
Trial: 9852907
Drug: Adenosine 100
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine 100 mumol/L
Trial: 9852907
Drug: Adenosine 50
RxNorm normalized name: adenosine 50 mcg/mL-NaCl 0.9% intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 50 mumol/L
Trial: 15177597
Drug: Nonpenetrating deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpenetrating deep sclerectomy with T‐flux implant
Trial: 9621483
Drug: EPI +
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPI + DEX (1,000 mg/m2 i.v.)
Trial: 2650646
Drug: Sodium warfarin
RxNorm normalized name: Warfarin Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium warfarin
Trial: 12519653
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg arecoline
Trial: 2880447
Drug: Oral temazepam
RxNorm normalized name: Temazepam
DrugBank: Temazepam acetate (DB14671)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral temazepam 20 mg
Trial: 19171070
Drug: Educational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational intervention for problem focused therapy (2 x 2 hours)
Trial: 24576321
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (100 mW) - best dose from phase 1
Trial: 25832687
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with GCP
Trial: 20886654
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment of rest for 5 min
Trial: 19034470
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis before skin incision (Group A)
Trial: 29943364
Drug: Usual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual therapy
Trial: 3898689
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of metyrapone and aminoglutethimide
Trial: 8067556
Drug: Topical EMLA
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical EMLA cream applied to the skin of the flank overlying the kidney 90 min prior to the ESWL procedure.
Trial: 25683285
Drug: Enzalutamide 160
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide 160 mg/day
Trial: 16945169
Drug: High-dose levamisole
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose levamisole combined with 5-FU and leucovorin
Trial: 14529939
Drug: Melphalan 100
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Melphalan 100 mg/m2 (three to four doses at 8- to 12-week intervals)
Trial: 7734897
Drug: Short-term treatment
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term treatment
Trial: 9428465
Drug: Dilution of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilution of predialysis sample with heparin or saline
Trial: 31465156
Drug: Tai Chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi therapy (Sun style Tai Chi exercise, 5 min warm-up, 45 min main exercise, 10 min meditation, conducted twice a week for 40 sessions over 5 months)
Trial: 20731878
Drug: Topical phenytoin
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical phenytoin 0.5%
Trial: 20731878
Drug: Cream (control)
RxNorm normalized name: Oral Cream
DrugBank: Coffea arabica seed, roasted (DB15603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream (control)
Trial: 16878680
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri formulation LR-2 (2 x 10(8) CFU per day)
Trial: 12874466
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium bicarbonate (0.9 g thrice daily)
Trial: 7813605
Drug: Oral liquid
RxNorm normalized name: ACAI ORAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral liquid application of 6 mg benperidol (BPD)
Trial: 7813605
Drug: Oral tablet
RxNorm normalized name: Oral Tablet
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tablet application of 6 mg benperidol (BPD)
Trial: 12972855
Drug: Both therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapies (interpretive and supportive)
Trial: 8568142
Drug: Patch tests
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch tests
Trial: 20493430
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg
Trial: 1425897
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of indomethacin
Trial: 11605920
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (10 microg/kg estimated fetal weight x 1.25 placental correction) given once at intrahepatic vein transfusion
Trial: 10803490
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment strategy (diuretics or beta-adrenergic blockers)
Trial: 12749757
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate 20 mg/day
Trial: 25616607
Drug: Active azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Active azithromycin (1 g) + placebo doxycycline
Trial: 25616607
Drug: Active doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active doxycycline (100 mg twice a day ×7 days) + placebo azithromycin
Trial: 25616607
Drug: Reverse therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reverse therapy (active doxycycline if first treated with active azithromycin)